2984505-88-4
Chemical Structure
AK-1690
- CAS No.: 2984505-88-4
- Formula:C51H56F2N5O11PS
- Molecular Weight:1016.05
InChIKey: BOMRVPKXCINUMI-STKXJIFCSA-N
SMILES: FC(C1=CC=C2C(C=C(C(N[C@@H](C(C)(C)C)C(N3[C@H](C(N4C[C@@H](C5=CC=CC=C5)OCC4)=O)C[C@H](OCCCCCC#CC6=CC=CC7=C6CN(C(CC8)C(NC8=O)=O)C7=O)C3)=O)=O)S2)=C1)(P(O)(O)=O)F
Biological Activity:
AK-1690 is a selective PROTAC degrader targeting STAT6 (DC50=1 nM) with a Ki of 6 nM against human STAT6. AK-1690 degrades STAT6 via the interaction of STAT6 with cereblon and a ubiquitin-like process. AK-1690 effectively depletes STAT6 protein in mouse liver and lung tissues, and is applicable to research related to leukemia, Hodgkin's lymphoma, follicular lymphoma, etc.[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
AK-1690 | 99.17% | AK-1690 is a selective PROTAC degrader targeting STAT6 (DC50=1 nM) with a Ki of 6 nM against human STAT6. AK-1690 degrades STAT6 via the interaction of STAT6 with cereblon and a ubiquitin-like process. AK-1690 effectively depletes STAT6 protein in mouse liver and lung tissues, and is applicable to research related to leukemia, Hodgkin's lymphoma, follicular lymphoma, etc.. |
||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
